MODSIM Pharma was founded in late 2018 as a spin-off from Uppsala University, with the support of the Uppsala Innovation Office. After some incubation period, the company is reaching the market with innovative solutions to characterize protein ligand binding and accelerate ligand design.
··· Hugo Gutiérrez de Terán ··· CEO, co-founder
Senior Lecturer in Computational Biochemistry, co-author of almost 100 publications. After his PhD on molecular modelling (UPF, Barcelona, 2004), Hugo has held academic positions in Santiago de Compostela University Hospital (non-tenured PI), Scripps Research Institute (Visiting scientist) and Uppsala University. His research has focused on structural modeling of G-protein coupled receptors and ligand design on these and other targets, in some cases is collaboration with the pharma industry.
········· Willem Jespers ········· CSO, co-founder
Willem obtained his PhD in Uppsala University (2020) and immediately moved to the pharmaceutical industry (Galapagos, BE). Academic research called him back, and he started in 2021 an Assistant Professorship in AI & Structure-Based Drug Discovery at Leiden University. He has co-authored twenty research papers and developed code for different SBDD tools.
········· Marc Willuhn ········· Business Developer
Organic chemist with over 20 years of experience in the industry including senior management roles. Used to prepare kilo amounts of drug development candidates and was part of several successful new drug applications. Knows how to restart his PC but thinks python is a snake.